Nuevo tratamiento dirigido y personalizado de neuroblastomas de alto riesgo.
Datos básicos
- NumeroConcesion:
- 2018_0096_CRC_FONT DE MORA
- Año inicial:
- 2018
- Año final:
- 2019
Documentos
- No hay documentos
Participantes
Financiadores
Resultados del Proyecto
Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas
Salvador-Coloma, C; (...); de Mora, JF
Article. 10.2147/OTT.S214319. 2019
Immunosuppressive profiles in liquid biopsy predict response to neoadjuvant chemotherapy in triple negative breast cancer
Salvador-Coloma, C; (...); Santaballa, A
Meeting Abstract. 10.1158/1538-7445.SABCS18-P3-11-16. 2019
Liquid Biopsies Provide Exosomal MicroRNAs as Biomarkers of the Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients
Morini, M; (...); Varesio, L
Meeting Abstract. 2018
Multi-parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review.
Oltra-Sastre M; (...); Garcia-Gomez JM
Article. 10.2174/1573405615666190109100503. 2019
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
Olivera, Gladys; (...); Alino, Salvador F.
Review. 10.20517/cdr.2018.25. 2019
Preliminarily results of the Oncohabitats Study: A multicentre validation of overall survival (OS) estimation of patients with glioblastoma (GBM) using vascular biomarkers
Alvarez-Torres, MD; (...); Garcia-Gomez, JM
Meeting Abstract. 10.1158/1538-7445.AM2019-4258. 2019
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.
Álvarez-Torres MDM; (...); García-Gómez JM
Article. 10.1002/jmri.26958. 2020
Upregulation of sFRP3 circulating expression levels correlates survival outcomes in glioblastoma
Bruixola, G; (...); Reynes, G
Meeting Abstract. 2019
Cita
Nuevo tratamiento dirigido y personalizado de neuroblastomas de alto riesgo. (2018_0096_CRC_FONT DE MORA). COLEGIO LA PURISIMA.FUNDACIÓN EDUCATIVA FRANCISCANAS DE LA INMACULADA; DONACIONES DE TERCEROS SIN CIF; FUNDACION INOCENTE INOCENTE. 2018-2019. IP:JAIME FONT DE MORA SAINZ.